GERD and Acid reflux

1
MegnaCure

• A new treatment for GERD/Acid Reflux
• From
• www.nanomeda.com
• www.nanosgroup.com

2
Do you want to go with this option?Big Problem?

• PPI drugs proven to cause vitamin B12 deficiency
• Tuesday, December 17, 2013 by PF LouisTags PPI
  drugs, B12 deficiency, vitamin supplements

No! Wait! We have an option for you. 100 safe
and effective solution for GERD/Acid Reflux
3
Big Problem

• According to a new study in the Journal of the
  American Medical Association, proton pump
  inhibitors (PPIs) and histamine 2 receptor
  antagonists (H2RAs) suppress gastric acid
  production, which can mean that the Vitamin B12
  in food is not properly absorbed into the body.
  Vitamin B12 deficiency is linked to serious
  health complications, such as anemia, nerve
  damage, and dementia
• The most commonly used PPIs are Prilosec,
  Prevacid, Nexium, Protonix, and Aciphex. The most
  popular H2RAs include Zantac, Pepcid, and
  Tagamet.

4
MegnaCure-Discovery
A newly discovered Compound for Acid Reflux/GERD
5
GERD/Acid Reflux
6
Market Size

• In recent years, GI prescriptions have remained
  one of the worlds largest therapeutic markets,
  with sales of more than 20 billion
• Given the large public need and the propensity
  for high returns, the gastroenterology market is
  set to expand. As an increasing pool of smaller
  specialty pharmaceutical players recognize the
  need and importance of developing innovative
  treatments to restore normal function of the GI
  system and improve patients quality of life, the
  doors to improved GI health are opening, and
  opportunity

7
Established

• A newly discovered compound
• Proof of concept
• No generic cliff
• Patent protection
• Pilot scale production
• Raw material qualification
• Manufacturing and QC protocols
• Machinery identified
• Formulation

8
Product

• Capsule
• Tablet
• Syrup
• Soft drink
• Chewing gum

Ready to Launch
9
Next

• cGMP manufacturing
• Preclinicals
• NDA
• Clinical trials
• Market/Partners/Exit

10
Funds

• 3million 1st round
• 3-5 years for exit and product launch
• We provide patent protection
• Direct investment on clinical trials

11
Contact
Mewa Singh, PhD mewasinghsandhu_at_hotmail.com 609-90
2-7128 www.nanomeda.com www.nanosgroup.com
12
MegnaCur-A new compoundforGERD/Acid Reflux